514 related articles for article (PubMed ID: 20212226)
21. Advances for the treatment of primary central nervous system lymphoma (review).
Yamanaka R; Tanaka R
Oncol Rep; 2004 Sep; 12(3):563-8. PubMed ID: 15289838
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of primary central nervous system lymphoma in the immunocompetent patient].
Sierra Del Rio M; Benouaich-Amiel A; Psimaras D; Dehais C; Hoang-Xuan K
Rev Neurol (Paris); 2008; 164(6-7):569-74. PubMed ID: 18565356
[TBL] [Abstract][Full Text] [Related]
23. Primary central nervous system lymphoma.
Freilich RJ; DeAngelis LM
Neurol Clin; 1995 Nov; 13(4):901-14. PubMed ID: 8584003
[TBL] [Abstract][Full Text] [Related]
24. Treatment of primary central nervous system lymphoma.
Shah GD; DeAngelis LM
Hematol Oncol Clin North Am; 2005 Aug; 19(4):611-27, v. PubMed ID: 16083826
[TBL] [Abstract][Full Text] [Related]
25. Treatment of primary central nervous system lymphoma.
Ekenel M; DeAngelis LM
Curr Neurol Neurosci Rep; 2007 May; 7(3):191-9. PubMed ID: 17488584
[TBL] [Abstract][Full Text] [Related]
26. Primary central nervous system (CNS) lymphoma in immunocompetent patients.
Plasswilm L; Herrlinger U; Korfel A; Weller M; Küker W; Kanz L; Thiel E; Bamberg M
Ann Hematol; 2002 Aug; 81(8):415-23. PubMed ID: 12223997
[TBL] [Abstract][Full Text] [Related]
27. The treatment of primary central nervous system lymphoma in 122 immunocompetent patients: a population-based study of successively treated cohorts from the British Colombia Cancer Agency.
Shenkier TN; Voss N; Chhanabhai M; Fairey R; Gascoyne RD; Hoskins P; Klasa R; Morris J; O'Reilly SE; Pickles T; Sehn L; Connors JM
Cancer; 2005 Mar; 103(5):1008-17. PubMed ID: 15651059
[TBL] [Abstract][Full Text] [Related]
28. An update on primary central nervous system lymphoma.
Iwamoto FM; DeAngelis LM
Hematol Oncol Clin North Am; 2006 Dec; 20(6):1267-85. PubMed ID: 17113462
[TBL] [Abstract][Full Text] [Related]
29. Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis.
Panageas KS; Elkin EB; DeAngelis LM; Ben-Porat L; Abrey LE
Cancer; 2005 Dec; 104(11):2466-72. PubMed ID: 16240449
[TBL] [Abstract][Full Text] [Related]
30. Primary central nervous system lymphoma.
Ferreri AJ; Reni M
Crit Rev Oncol Hematol; 2007 Sep; 63(3):257-68. PubMed ID: 17590348
[TBL] [Abstract][Full Text] [Related]
31. [Primary cerebral non-Hodgkin's lymphomas and primary malignant brain tumors in a well-defined geographical area. Population-based data from the registry of non-Hodgkin's lymphoma in western Denmark, LYFO and the cancer registry, Kraeftens Bekaempelse].
Jensen MK; d'Amore FA; Jensen MK; Christensen BE; Thorling K; Pedersen M; Johansen P; Boesen AM; Andersen E
Ugeskr Laeger; 1996 Jul; 158(31):4406-12. PubMed ID: 8759999
[TBL] [Abstract][Full Text] [Related]
32. Central nervous system dissemination in immunocompetent patients with aggressive lymphomas: incidence, risk factors and therapeutic options.
Ferreri AJ; Assanelli A; Crocchiolo R; Ciceri F
Hematol Oncol; 2009 Jun; 27(2):61-70. PubMed ID: 19247977
[TBL] [Abstract][Full Text] [Related]
33. Primary central nervous system lymphoma: essential points in diagnosis and management.
Paydas S
Med Oncol; 2017 Apr; 34(4):61. PubMed ID: 28315229
[TBL] [Abstract][Full Text] [Related]
34. [Investigation of diagnosis and treatment for primary central nervous system lymphoma].
Meng FG; Zhang K; Mao GS; Wang ZC; Wu CY; Liu K
Zhonghua Wai Ke Za Zhi; 2007 Nov; 45(22):1549-52. PubMed ID: 18282393
[TBL] [Abstract][Full Text] [Related]
35. Rising incidence of primary central nervous system lymphoma in Kumamoto, Japan.
Makino K; Nakamura H; Kino T; Takeshima H; Kuratsu J
Surg Neurol; 2006 Nov; 66(5):503-6. PubMed ID: 17084198
[TBL] [Abstract][Full Text] [Related]
36. Low-grade primary central nervous system lymphoma in immunocompetent patients.
Jahnke K; Thiel E; Schilling A; Herrlinger U; Weller M; Coupland SE; Krümpelmann U; Stein H; Korfel A
Br J Haematol; 2005 Mar; 128(5):616-24. PubMed ID: 15725082
[TBL] [Abstract][Full Text] [Related]
37. [Treatment results and the prognosis in patients with localization of non-Hodgkins-lymphoma in the central nervous system].
Paulus JA; Bos GM; Löwenberg B; Van Den Bent MJ
Ned Tijdschr Geneeskd; 1998 Oct; 142(40):2196-200. PubMed ID: 9864481
[TBL] [Abstract][Full Text] [Related]
38. Primary central nervous system lymphoma: a study of clinicopathological features and trend in western India.
Pasricha S; Gupta A; Gawande J; Trivedi P; Patel D
Indian J Cancer; 2011; 48(2):199-203. PubMed ID: 21768666
[TBL] [Abstract][Full Text] [Related]
39. Natural history and prognostic factors for survival in patients with acquired immune deficiency syndrome (AIDS)-related primary central nervous system lymphoma (PCNSL).
Raez LE; Patel P; Feun L; Restrepo A; Raub WA; Cassileth PA
Crit Rev Oncog; 1998; 9(3-4):199-208. PubMed ID: 10201628
[TBL] [Abstract][Full Text] [Related]
40. Primary central nervous system non-Hodgkin's lymphoma (PCNSL): does age and histology at presentation affect outcome?
Schaller C; Kelly PJ
Zentralbl Neurochir; 1996; 57(3):156-62. PubMed ID: 8794548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]